129
Views
0
CrossRef citations to date
0
Altmetric
General Medicine

Identification of ADAM23 as a Potential Signature for Psoriasis Using Integrative Machine-Learning and Experimental Verification

, , , , , , , & show all
Pages 6051-6064 | Received 24 Sep 2023, Accepted 15 Dec 2023, Published online: 21 Dec 2023

References

  • Walter K. Psoriasis. JAMA. 2022;327(19):1936. doi:10.1001/jama.2022.5270
  • Omland SH, Gniadecki R. Psoriasis inversa: a separate identity or a variant of psoriasis vulgaris? Clin Dermatol. 2015;33(4):456–461. doi:10.1016/j.clindermatol.2015.04.007
  • Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: a Review. JAMA. 2020;323(19):1945–1960. doi:10.1001/jama.2020.4006
  • Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20(6):1475. doi:10.3390/ijms20061475
  • Tokuyama M, Mabuchi T. New Treatment Addressing the Pathogenesis of Psoriasis. Int J Mol Sci. 2020;21(20):7488. doi:10.3390/ijms21207488
  • Campione E, Cosio T, Di Prete M, Lanna C, Dattola A, Bianchi L. Experimental Pharmacological Management of Psoriasis. J Exp Pharmacol. 2021;13:725–737. doi:10.2147/JEP.S265632
  • Campione E, Mazzilli S, Di Prete M, et al. The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway. Front Med Lausanne. 2022;9:760852. doi:10.3389/fmed.2022.760852
  • Al-Hammadi A, Ruszczak Z, Magariños G, Chu CY, El Dershaby Y, Tarcha N. Intermittent use of biologic agents for the treatment of psoriasis in adults. J Eur Academy Dermatol Venereol. 2021;35(2):360–367. doi:10.1111/jdv.16803
  • Gordon KB, Strober B, Lebwohl M, et al. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled Phase 3 trials. Lancet. 2018;392(10148):650–661. doi:10.1016/S0140-6736(18)31713-6
  • Uppala R, Tsoi LC, Harms PW, et al. “Autoinflammatory psoriasis”-genetics and biology of pustular psoriasis. Cell Mol Immunol. 2021;18(2):307–317. doi:10.1038/s41423-020-0519-3
  • Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32(1):227–255. doi:10.1146/annurev-immunol-032713-120225
  • Lebwohl M, Soliman AM, Yang H, Wang J, Freimark J, Puig L. Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis. J DermatolTreat. 2022;33(4):2094–2101. doi:10.1080/09546634.2021.1919287
  • Gottlieb AB, Mease PJ, Kirkham B, et al. Secukinumab Efficacy in Psoriatic Arthritis: machine Learning and Meta-analysis of Four Phase 3 Trials. J Clin Rheumatol. 2021;27(6):239–247. doi:10.1097/RHU.0000000000001302
  • Meienberger N, Anzengruber F, Amruthalingam L, et al. Observer-independent assessment of psoriasis-affected area using machine learning. J Eur Academy Dermatol Venereol. 2020;34(6):1362–1368. doi:10.1111/jdv.16002
  • Martínez BA, Shrotri S, Kingsmore KM, Bachali P, Grammer AC, Lipsky PE. Machine learning reveals distinct gene signature profiles in lesional and nonlesional regions of inflammatory skin diseases. Sci Adv. 2022;8(17):eabn4776. doi:10.1126/sciadv.abn4776
  • Hughes TK, Wadsworth MH, Gierahn TM, et al. Second-Strand Synthesis-Based Massively Parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin Pathologies. Immunity. 2020;53(4):878–94.e7. doi:10.1016/j.immuni.2020.09.015
  • Liu Y, Wang H, Taylor M, et al. Classification of human chronic inflammatory skin disease based on single-cell immune profiling. Sci Immunol. 2022;7(70):eabl9165. doi:10.1126/sciimmunol.abl9165
  • Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. 2012;41(D1):D991–D995. doi:10.1093/nar/gks1193
  • Suárez-Fariñas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol. 2012;132(11):2552–2564. doi:10.1038/jid.2012.184
  • Correa da Rosa J, Kim J, Tian S, Tomalin LE, Krueger JG, Suárez-Fariñas M. Shrinking the Psoriasis Assessment Gap: early Gene-Expression Profiling Accurately Predicts Response to Long-Term Treatment. J Invest Dermatol. 2017;137(2):305–312. doi:10.1016/j.jid.2016.09.015
  • Reischl J, Schwenke S, Beekman JM, Mrowietz U, Stürzebecher S, Heubach JF. Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol. 2007;127(1):163–169. doi:10.1038/sj.jid.5700488
  • Bigler J, Rand HA, Kerkof K, Timour M, Russell CB. Cross-study homogeneity of psoriasis gene expression in skin across a large expression range. PLoS One. 2013;8(1):e52242. doi:10.1371/journal.pone.0052242
  • Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. doi:10.1186/gb-2004-5-10-r80
  • Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e47. doi:10.1093/nar/gkv007
  • Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
  • Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–2914. doi:10.1093/bioinformatics/btv300
  • Breiman L. Random Forests. Machine Learning. 2001;45(1):5–32. doi:10.1023/A:1010933404324
  • Tibshirani R. Regression Shrinkage and Selection via The Lasso: a Retrospective. J Royal Statistical Society Series B. 2011;73(3):273–282. doi:10.1111/j.1467-9868.2011.00771.x
  • Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;9(1):559. doi:10.1186/1471-2105-9-559
  • Yoon S, Kim S. AdaBoost-based multiple SVM-RFE for classification of mammograms in DDSM. BMC Med Inform Decis Mak. 2009;9 Suppl 1(Suppl 1):S1. doi:10.1186/1472-6947-9-S1-S1
  • Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
  • Huang J, Feng X, Zeng J, et al. Aberrant HO-1/NQO1-Reactive Oxygen Species-ERK Signaling Pathway Contributes to Aggravation of TPA-Induced Irritant Contact Dermatitis in Nrf2-Deficient Mice. J Immunol. 2022;208(6):1424–1433. doi:10.4049/jimmunol.2100577
  • Ge Y, Luo J, Li D, et al. Deficiency of vitamin D receptor in keratinocytes augments dermal fibrosis and inflammation in a mouse model of HOCl-induced scleroderma. Biochem Biophys Res Commun. 2022;591:1–6. doi:10.1016/j.bbrc.2021.12.085
  • Guo F, Zhu X, Wu Z, Zhu L, Wu J, Zhang F. Clinical applications of machine learning in the survival prediction and classification of sepsis: coagulation and heparin usage matter. J Transl Med. 2022;20(1):265. doi:10.1186/s12967-022-03469-6
  • Yue S, Li S, Huang X, et al. Machine learning for the prediction of acute kidney injury in patients with sepsis. J Transl Med. 2022;20(1):215. doi:10.1186/s12967-022-03364-0
  • Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. doi:10.1056/NEJMra0804595
  • Elizondo DM, Andargie TE, Marshall KM, Zariwala AM, Lipscomb MW. Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor. J Leukoc Biol. 2016;100(5):855–864. doi:10.1189/jlb.2HI1115-525R
  • Kim HA, Park WJ, Jeong HS, et al. Leucine-rich glioma inactivated 3 regulates adipogenesis through ADAM23. Biochim Biophys Acta. 2012;1821(6):914–922. doi:10.1016/j.bbalip.2012.02.010
  • Kim HA, Kwon NS, Baek KJ, Kim DS, Yun HY. Leucine-rich glioma inactivated 3 and tumor necrosis factor-α regulate mutually through NF-κB. Cytokine. 2015;72(2):220–223. doi:10.1016/j.cyto.2014.12.023
  • Kim IW, Jeong HS, Kwon NS, Baek KJ, Yun HY, Kim DS. LGI3 promotes human keratinocyte differentiation via the Akt pathway. Exp Dermatol. 2018;27(11):1224–1229. doi:10.1111/exd.13766
  • Yu J, Zhao Q, Wang X, et al. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun. 2022;133:102916. doi:10.1016/j.jaut.2022.102916
  • Goldsmith AP, Gossage SJ, ffrench-Constant C. ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons. J Neurosci Res. 2004;78(5):647–658. doi:10.1002/jnr.20320
  • Hsia HE, Tüshaus J, Brummer T, Zheng Y, Scilabra SD, Lichtenthaler SF. Functions of ‘A disintegrin and metalloproteases (ADAMs)’ in the mammalian nervous system. Cell Mol Life Sci. 2019;76(16):3055–3081. doi:10.1007/s00018-019-03173-7
  • Markus-Koch A, Schmitt O, Seemann S, et al. ADAM23 promotes neuronal differentiation of human neural progenitor cells. Cell Mol Biol Lett. 2017;22(1):16. doi:10.1186/s11658-017-0045-1
  • Riol-Blanco L, Ordovas-Montanes J, Perro M, et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature. 2014;510(7503):157–161. doi:10.1038/nature13199
  • Cohen JA, Edwards TN, Liu AW, et al. Cutaneous TRPV1(+) Neurons Trigger Protective Innate Type 17 Anticipatory Immunity. Cell. 2019;178(4):919–32.e14. doi:10.1016/j.cell.2019.06.022
  • Cai X, Han M, Lou F, et al. Tenascin C(+) papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis. Nat Commun. 2023;14(1):2004.
  • Liluashvili S, Kituashvili T. Dermatology Life Quality Index and disease coping strategies in psoriasis patients. Postepy Dermatol Alergol. 2019;36(4):419–424. doi:10.5114/ada.2018.75810
  • Weiglein A, Gaffal E, Albrecht A. Probing the Skin-Brain Axis: new Vistas Using Mouse Models. Int J Mol Sci. 2022;23(13):7484. doi:10.3390/ijms23137484